Clostridium difficile infection among hematopoietic stem cell transplant recipients: beyond colitis.
about
Antibiotic therapy and Clostridium difficile infection - primum non nocere - first do no harmRisk for Clostridium difficile Infection After Allogeneic Hematopoietic Cell Transplant Remains Elevated in the Postengraftment Period.Rethinking Antimicrobial Prophylaxis in the Transplant Patient in the World of Emerging Resistant Organisms-Where Are We Today?
P2860
Clostridium difficile infection among hematopoietic stem cell transplant recipients: beyond colitis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Clostridium difficile infectio ...... nt recipients: beyond colitis.
@ast
Clostridium difficile infectio ...... nt recipients: beyond colitis.
@en
Clostridium difficile infectio ...... nt recipients: beyond colitis.
@nl
type
label
Clostridium difficile infectio ...... nt recipients: beyond colitis.
@ast
Clostridium difficile infectio ...... nt recipients: beyond colitis.
@en
Clostridium difficile infectio ...... nt recipients: beyond colitis.
@nl
prefLabel
Clostridium difficile infectio ...... nt recipients: beyond colitis.
@ast
Clostridium difficile infectio ...... nt recipients: beyond colitis.
@en
Clostridium difficile infectio ...... nt recipients: beyond colitis.
@nl
P2860
P1476
Clostridium difficile infectio ...... nt recipients: beyond colitis.
@en
P2093
Carolyn D Alonso
Kieren A Marr
P2860
P304
P356
10.1097/QCO.0B013E3283630C4C
P577
2013-08-01T00:00:00Z